Humacyte Inc Warrant
HUMAW
HUMAW was delisted on the 25th of August, 2026.
10 hedge funds and large institutions have $448K invested in Humacyte Inc Warrant in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
0.15% more ownership
Funds ownership: 0.75% → 0.9% (+0.15%)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
54% less capital invested
Capital invested by funds: $971K → $448K (-$523K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
+$210K |
| 2 |
LPL Financial
San Diego,
California
|
+$26.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$58K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$31K |
| 3 |
RL
RPO LLC
Stamford,
Connecticut
|
-$23.9K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$18K |
| 5 |
HF
HRT Financial
New York
|
-$6.69K |
HUMAW Hedge Fund Activity: Q4 2022 in Review
10 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q4 2022, worth a combined $448K — down 54% from $971K a quarter earlier.
Fund positioning in HUMAW was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 4 trimmed.
The largest buyer was Josh Arnold Investment Consultant, opening a new position worth an estimated $210K. The largest seller was Sio Capital Management, exiting entirely with an estimated $58K sold.
- 10 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $448K of Humacyte Inc Warrant stock for Q4 2022, down 54% quarter-over-quarter.
- 2 funds opened new Humacyte Inc Warrant positions in Q4 2022 and 2 closed out, a net change of 0 holders.
- The largest Humacyte Inc Warrant buyer in Q4 2022 was Josh Arnold Investment Consultant, an estimated $210K added.
- The largest Humacyte Inc Warrant seller in Q4 2022 was Sio Capital Management, an estimated $58K sold.
Based on aggregated 13F filings for Q4 2022.